Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Approved Drug Products containing Almotriptan Malate listed in the FDA Orange Book. Original Data : FDA Website

Client Email

Product

Almotriptan Malate
Almotriptan
FDA Orange Book

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Almotriptan Malate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

15 API Suppliers, 6 USDMF, 1 CEP/COS, 5 EU WC, 3 NDC API, 9 Listed Suppliers, $ API Reference Price

15 API Suppliers
6 USDMF
1 CEP/COS
5 EU WC
3 NDC API
9 Listed Suppliers
$ API Reference Price

PRICE INFORMATION

API Reference Price, API Exports, API Imports

API Reference Price
API Exports
API Imports

FINISHED DOSAGE FORMULATIONS

25 FDF Dossiers, 8 FDA Orange Book, 11 Europe, 6 Canada

25 FDF Dossiers
8 FDA Orange Book
11 Europe
6 Canada

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 12.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 6.25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 12.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 6.25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Rochem International Inc, 14 SPI Pharma, 2 Seqens, 2 DKSH, 2 Jai Radhe Sales, 4 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 10 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 3 Actylis, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 20 BASF, 10 Corel Pharma Chem, 4 DFE Pharma, 2 Finar, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 6 Microlex e.U, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 3 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 15 Roquette, 6 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

48 Fillers, Diluents & Binders, 45 Coating Systems & Additives, 30 Direct Compression, 29 Disintegrants & Superdisintegrants, 27 Controlled & Modified Release, 19 Thickeners and Stabilizers, 19 Granulation, 15 Solubilizers, 14 Chewable & Orodispersible Aids, 14 Co-Processed Excipients, 12 Taste Masking, 11 Film Formers & Plasticizers, 10 Lubricants & Glidants, 10 Topical, 9 Parenteral, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Coloring Agents, 3 Rheology Modifiers, 2 Emulsifying Agents

48 Fillers, Diluents & Binders
45 Coating Systems & Additives
30 Direct Compression
29 Disintegrants & Superdisintegrants
27 Controlled & Modified Release
19 Thickeners and Stabilizers
19 Granulation
15 Solubilizers
14 Chewable & Orodispersible Aids
14 Co-Processed Excipients
12 Taste Masking
11 Film Formers & Plasticizers
10 Lubricants & Glidants
10 Topical
9 Parenteral
5 Empty Capsules
5 API Stability Enhancers
4 Vegetarian Capsules
4 Coloring Agents
3 Rheology Modifiers
2 Emulsifying Agents

DIGITAL CONTENT

2 NEWS #PharmaBuzz

2 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 4 Finished Drug Prices

1 US Medicaid Prescriptions
4 Finished Drug Prices

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP, 1 Others

2 USP
1 Others

$ API Ref.Price (USD/KG) : 9,514 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

8 All

01 2AJANTA PHARMA LTD

02 2JANSSEN PHARMS

03 2MYLAN

04 2TEVA PHARMS USA

filter Dosage Reset all filters

8 All

01 8TABLET;ORAL

filter Regulatory Info Reset all filters

8 All

01 2DISCN

02 6RX

filter Brand Name Reset all filters

8 All

01 6ALMOTRIPTAN MALATE

02 2AXERT

filter RLD Reset all filters

8 All

01 6No

02 2Yes

FDF Dossiers
FDA Orange Book
Europe
Canada

List of Suppliers

Product Main Page

01

AJANTA PHARMA LTD

Boulder Peptide 2024

Not Confirmed

AJANTA PHARMA LTD

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

ALMOTRIPTAN MALATE

Brand Name : ALMOTRIPTAN MALATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 6.25MG BASE

Approval Date : 2016-03-03

Application Number : 205523

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

AJANTA PHARMA LTD

Boulder Peptide 2024

Not Confirmed

AJANTA PHARMA LTD

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

ALMOTRIPTAN MALATE

Brand Name : ALMOTRIPTAN MALATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 12.5MG BASE

Approval Date : 2016-03-03

Application Number : 205523

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

JANSSEN PHARMS

Boulder Peptide 2024

Not Confirmed

JANSSEN PHARMS

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code :

ALMOTRIPTAN MALATE

Brand Name : AXERT

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 6.25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 2001-05-07

Application Number : 21001

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

JANSSEN PHARMS

Boulder Peptide 2024

Not Confirmed

JANSSEN PHARMS

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code :

ALMOTRIPTAN MALATE

Brand Name : AXERT

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 12.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 2001-05-07

Application Number : 21001

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

TEVA PHARMS USA

Boulder Peptide 2024

Not Confirmed

TEVA PHARMS USA

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

ALMOTRIPTAN MALATE

Brand Name : ALMOTRIPTAN MALATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 6.25MG BASE

Approval Date : 2015-07-07

Application Number : 78027

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

TEVA PHARMS USA

Boulder Peptide 2024

Not Confirmed

TEVA PHARMS USA

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

ALMOTRIPTAN MALATE

Brand Name : ALMOTRIPTAN MALATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 12.5MG BASE

Approval Date : 2015-07-07

Application Number : 78027

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

MYLAN

Boulder Peptide 2024

Not Confirmed

MYLAN

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

ALMOTRIPTAN MALATE

Brand Name : ALMOTRIPTAN MALATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 6.25MG BASE

Approval Date : 2015-11-09

Application Number : 205171

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

MYLAN

Boulder Peptide 2024

Not Confirmed

MYLAN

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : No

TE Code : AB

ALMOTRIPTAN MALATE

Brand Name : ALMOTRIPTAN MALATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 12.5MG BASE

Approval Date : 2015-11-09

Application Number : 205171

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?